Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of UI018 vs Co-administration of UIC201806 and UIC201602 in Healthy Volunteers
NCT05085184Phase 1Unknown
- Sponsor
- Korea United Pharm Inc.
- Start
- Sep 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin and omega-3-acid triglycerides in mixed hyperlipidemia (2 arms), sponsored by Korea United Pharm Inc. Primary endpoints: Maximum Concentration and Area Under the Curve. Status: unknown.
02
Drugs
atorvastatinomega-3-acid triglycerides
03
Conditions
mixed hyperlipidemia
Beyond the preview
Go deeper on NCT05085184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05085184.